ALA Diagnostics, S.L. 

Revolutionizing Multiple Sclerosis diagnosis

OWNER

Jose Ramon Montero (See Profile)


Sector

Diagnostics

Stage

Development, market readiness, clinical trial

Country

Spain


Patented recombinant protein whose activity as a diagnostic biomarker has been validated in 598 human samples

Our diagnostic algorithm increases diagnostic accuracy > 95%

It is the unique specific biomarker that exists for the diagnostic of Multiple Sclerosis in blood clinically validated

It is fast, easy, cheap, non-invasive, suitable for early diagnostic of MS and easy to integrate into clinical routine

NDAs signed with IVD multinational companies. Ongoing negotiations with market leaders

Status

Approved

IP Type

Patent

Time

15 years

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

The use of our biomarker in Multiple Sclerosis
New patent submitted in December 2021. Combination of biomarkers

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: July 28th, 2022

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

  • AsistensiAllowing migrants to easily purchase the medical he...

©2022 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar